Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Captor Therapeutics S.A. Director's Dealing 2025

Sep 25, 2025

5552_rns_2025-09-25_8424de03-ff1c-43d8-82de-dfb5f155fdf9.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Transaction notification as referred to in Article 19(1) of the MAR Regulation
1 Details of the person discharging managerial responsibilities/closely related to him/her
a) Name Charles Kunsch
2 Reason for notification
a) Position/status Member of the Supervisory Board
b) Initial
notification/change
Initial notification
3 Issuer data
a) Name Captor Therapeutics S.A.
b) LEI 259400JHH1S2I2S4O735
4 Transaction details: this column should be completed for (i) each type of instrument;
(ii) each type of transaction; (iii) date; and (iv) each place where the transactions were
carried out
a) Description
of
the
financial
instrument,
type
of
instrument
Identification code
Ordinary bearer shares
ISIN: PLCPTRT00014
b) Type of transaction Subscription
c) Price and volume Price Volume
105,2
PLN
1052
d) Summary
information
-
Total volume
1052
-
Price
105,2
PLN
e) Transaction date 2025-09-24
f) Place of transaction Outside a trading market

_______________________